CORMORANT ASSET MANAGEMENT, LP – Atea Pharmaceuticals, Inc. Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$8.80M
portfolio value
CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:
-19.86%
quarter
Atea Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -2.18M | $5.69 | 1.54M | |
| Q2 2022 | share | 0.00% | 0 shares | -186K | $7.1 | 1.54M | |
| Q1 2022 | share | Decrease | -7.88% | -132.26K shares | -3.84M | $7.22 | 1.54M |
| Q4 2021 | share | Decrease | -65.93% | -3.24M shares | -157.78M | $9.05 | 1.67M |
| Q3 2021 | share | Decrease | -23.12% | -1.48M shares | 35.08M | $35.06 | 4.92M |
| Q2 2021 | share | 0.00% | 0 shares | -258.18M | $21.48 | 6.41M | |
| Q1 2021 | share | 0.00% | 0 shares | 136.07M | $61.75 | 6.41M | |
| Q4 2020 | share | Increase | 0.00% | 6.41M shares | 259.83M | $41.78 | 6.41M |